Actively Recruiting
Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia
Led by Tampere University · Updated on 2024-06-20
150
Participants Needed
1
Research Sites
80 weeks
Total Duration
On this page
Sponsors
T
Tampere University
Lead Sponsor
T
Tampere University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Assessment of a novel diagnostic method for screening and diagnosing chronic limb-threatening ischemia (CLTI). Using hyperspectral and thermal imaging, the perfusion and oxygenation in the lower limbs will be studied in healthy and unhealthy individuals.
CONDITIONS
Official Title
Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- For CLTI patients, age older than 50 years
- For the age control group, age older than 50 years with no cardiovascular disease and ankle-brachial index (ABI) between 0.9 and 1.3
- For the healthy group, age between 18 and 50 years with no history of cardiovascular disease
- Volunteering to participate in the study
You will not qualify if you...
- Unable to give informed consent
- Declines to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tampere University
Tampere, Pirkanmaa, Finland, 33720
Actively Recruiting
Research Team
N
Niku Oksala, MD, PhD, DSc
CONTACT
A
Antti Vehkaoja, DSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here